Sigma-Aldrich Investor Relations Sigma-Aldrich Investor Home Home Sigma-Aldrich home page



Investor Relations

Events & Presentations

Jun 11, 2013 at 8:00 AM PT
Goldman Sachs 34th Annual Global Healthcare Conference
Listen to Webcast Listen to Webcast

Jun 3, 2013 at 8:30 AM ET
Jefferies 2013 Healthcare Conference
Listen to Webcast Listen to Webcast

View all events & presentations »

Corporate Profile

Sigma-Aldrich is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university and government institutions, hospitals and industry. The Company operates in 40 countries and has nearly 9,000 employees whose objective is to provide excellent service worldwide. Sigma-Aldrich is committed to accelerating customer success through innovation and leadership in Life Science and High Technology. For more information about Sigma-Aldrich, please visit its website at http://www.sigma-aldrich.com .

Recent Releases

Jun 4, 2013
SAFC Strengthens Biopharmaceutical Market Presence in Asia with Commercial Licensing of CHOZN® Cell Line Bioproduction Platform

May 30, 2013
Sigma-Aldrich Corporation Presentations At Three Upcoming Conferences To Be Webcast Live

May 13, 2013
Sigma-Aldrich Launches Novel Search Engine for Peer-Reviewed Literature, Biological Pathway Data and Technology Queries

View all releases »


Featured Documents
 

© 2013 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher